Materialise NV (NASDAQ: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced its plans to pursue an additional listing of its ordinary shares on Euronext Brussels, to complement the existing NASDAQ listing of its American depositary shares (ADSs) representing ordinary shares, and to launch an ADS buyback program.
“At Materialise, we are proud of our heritage and our global ambitions,” says CEO Brigitte de Vet. “Pursuing an additional listing on Euronext Brussels is a natural step in broadening our investor base while continuing to build on our global growth strategy. By aligning our roots with our vision, we aim to create long-term value for shareholders and support innovation across industries from healthcare to aerospace, and beyond.”
The listing is designed to further enhance Materialise’s profile and expand its investor base, reflecting the company’s commitment to both US and European investors.
While the company’s NASDAQ listing remains integral to the company’s global strategy, an additional listing will allow investors in Materialise to hold and deal in shares on Euronext (and become shareholders of the company) as well as to hold and deal in ADSs on Nasdaq.
The plan to pursue an additional listing represents a proactive step to connect its heritage with its global ambitions, ensuring the company’s ability to drive growth and deliver meaningful impact in multiple sectors.
MTLS shares surged 36 cents, or 6.6%, to $5.84.
